Literature DB >> 10564702

The influence of streptozotocin diabetes and metformin on erythrocyte volume and on the membrane potential and the contractile characteristics of the extensor digitorum longus and soleus muscles in rats.

M McGuire1, M MacDermott.   

Abstract

The effects of streptozotocin (STZ) diabetes and the antihyperglycaemic agent metformin on the contractile characteristics of the limb skeletal muscles and on erythrocyte volume were examined in rats. After 8 weeks of diabetes, the tetanic tension of the extensor digitorum longus (EDL) muscle decreased and the half-relaxation time of the soleus muscle increased. Endurance decreased in both muscles. Metformin treatment of the diabetic rats did not prevent the development of these contractile changes. Diabetes induced depolarisation in the EDL and soleus muscles. Following exposure to insulin, both muscles repolarized. Metformin treatment of control rats induced depolarisation in the EDL and soleus muscles, but in the depolarised EDL and soleus muscles of the diabetic rats metformin treatment caused no further depolarisation. The muscles of metformin-treated control and diabetic rats hyperpolarized in the presence of insulin. Diabetes caused an increase in the volume of the blood erythrocytes. This was prevented by metformin treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564702

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  11 in total

Review 1.  Activation of AMPK and its Impact on Exercise Capacity.

Authors:  Ellen Niederberger; Tanya S King; Otto Quintus Russe; Gerd Geisslinger
Journal:  Sports Med       Date:  2015-11       Impact factor: 11.136

2.  Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy?

Authors:  Carly S Gordon; Antonio S Serino; Matthew P Krause; Jonathan E Campbell; Enzo Cafarelli; Olasunkanmi A J Adegoke; Thomas J Hawke; Michael C Riddell
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

3.  Upregulation of PPARbeta/delta is associated with structural and functional changes in the type I diabetes rat diaphragm.

Authors:  Nadège Salvi; Aziz Guellich; Pierre Michelet; Alexandre Demoule; Morgan Le Guen; Laure Renou; Gisèle Bonne; Bruno Riou; Olivier Langeron; Catherine Coirault
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

4.  The effects of neuropeptide Y on skeletal muscle contractile properties in streptozotocin diabetic rats.

Authors:  M Ljubisavljevic; A Qureshi; N Nagelkerke
Journal:  Mol Cell Biochem       Date:  2009-07-19       Impact factor: 3.396

5.  Elevated extracellular glucose and uncontrolled type 1 diabetes enhance NFAT5 signaling and disrupt the transverse tubular network in mouse skeletal muscle.

Authors:  Erick O Hernández-Ochoa; Patrick Robison; Minerva Contreras; Tiansheng Shen; Zhiyong Zhao; Martin F Schneider
Journal:  Exp Biol Med (Maywood)       Date:  2012-09-10

6.  Streptozotocin diabetes attenuates the effects of nondepolarizing neuromuscular relaxants on rat muscles.

Authors:  Lina Huang; Dan Chen; Shitong Li
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

7.  Diabetic Myopathy and Mechanisms of Disease.

Authors:  Erick O Hernández-Ochoa; Camilo Vanegas
Journal:  Biochem Pharmacol (Los Angel)       Date:  2015-10-31

8.  Acute Elevated Glucose Promotes Abnormal Action Potential-Induced Ca2+ Transients in Cultured Skeletal Muscle Fibers.

Authors:  Erick O Hernández-Ochoa; Quinton Banks; Martin F Schneider
Journal:  J Diabetes Res       Date:  2017-08-01       Impact factor: 4.011

9.  Gene expression profiling in the type 1 diabetes rat diaphragm.

Authors:  Erik van Lunteren; Michelle Moyer
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

10.  Cytoprotective effect of Semecarpus anacardium against toxicity induced by Streptozotocin in rats.

Authors:  Jaya Aseervatham; Shanthi Palanivelu; Panchanadham Sachdanandam
Journal:  J Exp Pharmacol       Date:  2010-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.